North Carolina Man Pleads Guilty to Conspiring to Distribute Suboxone, Oxycodone, other Pain Medications
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • North Carolina Man Pleads Guilty to Conspiring to Distribute Suboxone, Oxycodone, other Pain Medications

North Carolina Man Pleads Guilty to Conspiring to Distribute Suboxone, Oxycodone, other Pain Medications

July 29, 2021
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Public Information Office
Phone Number: (571) 362-1934

ABINGDON, Va., – A Dobson, North Carolina man pleaded guilty yesterday to conspiring to distribute medically illegitimate prescriptions for Schedule II opioids and Suboxone, as well as conspiring to use, in the course of the distribution of controlled substances, the DEA registration number of another person.

According to court documents, Charles Wilson Adams Jr., 50, worked for “Company L” that operated medical clinics in the Western District of Virginia, including in the Galax, Lynchburg, and Christiansburg areas. The clinic focused on pain management and opioid addiction treatment.

Adams worked as a counselor for Company L, though he had not applied to the Virginia Board of Counseling to become a Certified Substance Abuse Counselor. Adams was referred to inside Company L as “Dr.” but has never been a medical practitioner or possessed the authority to prescribe controlled substances.

Adams admitted that he and other non-medical professionals exerted influence or control over medical decisions and treatment of patients, including the prescribing of Schedule II pain medications and Suboxone, a Schedule III drug used to treat opioid addiction.

As part of his plea, Adams also acknowledged Company L employees pre-signed blank prescriptions for distribution to patients without office visits.  Further, at the direction of Company L’s owner and others, employees used DEA registration numbers of medical providers to prescribe Suboxone to patients, even when those providers were in other cities or states and did not see the patients. Adams was aware of Company L’s practices and their illegitimacy yet took part in them anyway.  

“Our investigation into Adams’ illegal distribution of highly addictive pain medication at the height of an overdose epidemic, emphasizes his criminal indifference for human life,” said Jarod Forget, Special Agent in Charge of the DEA Washington Field Office. “Today’s guilty plea emphasizes our commitment to the tireless work of investigating and prosecuting those responsible for fueling opioid addiction and deadly overdoses in our area – saving lives in our communities.”

“Adams chose to use his position to assist in the illegal distribution of powerful opioids rather than their use for legitimate medical purposes, thus causing additional harm to the community,” Acting United States Attorney Bubar stated today. “We are grateful for the extensive investigation conducted by federal, state, and local law enforcement located in three states, whose hard work is holding the defendant accountable for his crimes.”

“This individual put the health of patients and his community in jeopardy by participating in the prescribing of dangerous drugs and other medical treatments indiscriminately when he was not qualified to do so,” said Attorney General Herring. “The opioid crisis continues to devastate communities and families across Virginia, and we will not tolerate healthcare providers who do not handle or prescribe highly addictive drugs appropriately and safely. I want to thank our local, state, and federal partners for their help on this important case as well as my award-winning Medicaid Control Fraud Unit for their continued hard work and dedication.”

“Prescription drugs are to be prescribed for legitimate medical reasons by appropriately licensed medical professionals,” said Special Agent in Charge Maureen Dixon of the Office of the Inspector General for the Department of Health and Human Services. “HHS-OIG will continue to work with our federal, state, and local law enforcement partners to keep our communities safe from illegal prescription drugs.”

Adams pleaded guilty to one count of conspiring to use, in the course of the distribution of controlled substances, the DEA registration number of another, one count of conspiring to distribute Suboxone, and one count of conspiring to distribute oxycodone, hydrocodone, morphine, methadone, and fentanyl. He is scheduled to be sentenced on October 29, 2021.  A federal district court judge will determine any sentence after considering the U.S. Sentencing Guidelines and other statutory factors.

The Drug Enforcement Administration, including offices in southwest Virginia, North Carolina, and South Carolina, Virginia Medicaid Fraud Control Unit, and the Department of Health and Human Service are investigating the case, with the assistance of the Carroll County (Va.) Sheriff’s Office, Mt. Pleasant (S.C.) Police Department, Christiansburg (Va.) Police Department, Mt. Airy (N.C.) Police Department, Amherst County (Va.) Sheriff's Office, and the U.S. Attorney Offices of the Middle District of North Carolina and District of South Carolina.

##

Download Press Release
###
Opioids Synthetic Opioids Oxycodone
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Ibrar A. Mian Special Agent in Charge - Washington, DC
@DEAWashingtonDC
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster